On October 28, 2021, Partner Courtney Brinckerhoff will present, “Patenting Issues Facing Innovators in the Life Sciences Including Sections 101, 112 and in Connection with COVID-19 Vaccines,” during the American Intellectual Property Law Association (AIPLA) 2021 Annual Meeting, being held October 28-30, 2021.
Additional programs during the patent prosecution track include:
- An Exemplary Study: Comparing Europe and US Guidance Examples and Recent Developments in Patenting Computer-Implemented Inventions
Mike Jennings, AA Thornton, London, UK - Following the Example: Effective Claim Drafting for AI/ML and Computer Simulation in Europe and the US
Michael W. Piper, Conley Rose, Plano, TX - Current Patenting Issues in Europe Facing Life Sciences/Biotech Innovators, and Effective Claim Drafting Strategies to Avoid Pitfalls
Andrew Bentham, JA Kemp, London, United Kingdom
The AIPLA Annual Meeting is a three-day event that brings together over 1,000 intellectual property practitioners to network and discuss issues relevant to their practice.
For more information please visit the program website.
To register to attend the event in person, click here and to attend virtually, click here.
People
Related Insights
22 April 2024
Foley Ignite
AI Regulatory and Legal Issues Today: A Conversation with Natasha Allen
As is the case with most emerging technologies, developments in artificial intelligence are quickly outpacing regulations, and with this comes a variety of important legal considerations.
22 April 2024
Foley Ignite
The Complex Terrain of the Video Game Industry: Challenges and Opportunities
The video game industry is brimming with innovation, competition, and transformative technological advancements.
22 April 2024
Labor & Employment Law Perspectives
Utah Enacts H.B. 55, Impacting the Use of Confidentiality Clauses in Employment Settlement Agreements
On March 13, 2024, Governor Spencer Cox signed House Bill (H.B.) 55 into law, making Utah the latest state to restrict the use of certain nondisclosure and non-disparagement agreements relating to sexual assault or sexual harassment claims.